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Abstract: Toxic metals have been implicated in the pathogenesis of pancreatic cancer. Human
exposure to mercury is widespread, but it is not known how often mercury is present in the human
pancreas and which cells might contain mercury. We therefore aimed to determine, in people
with and without pancreatic cancer, the distribution and prevalence of mercury in pancreatic cells.
Paraffin-embedded sections of normal pancreatic tissue were obtained from pancreatectomy samples
of 45 people who had pancreatic adenocarcinoma, and from autopsy samples of 38 people without
pancreatic cancer. Mercury was identified using two methods of elemental bio-imaging: (1) With
autometallography, inorganic mercury was seen in islet cells in 14 of 30 males (47%) with pancreatic
cancer compared to two of 17 males (12%) without pancreatic cancer (p = 0.024), and in 10 of 15
females (67%) with pancreatic cancer compared to four of 21 females (19%) without pancreatic
cancer (p = 0.006). Autometallographic mercury was present in acinar cells in 24% and in periductal
cells in 11% of people with pancreatic cancer, but not in those without pancreatic cancer. (2) Laser
ablation-inductively coupled plasma-mass spectrometry confirmed the presence of mercury in
islets that stained with autometallography and detected cadmium, lead, chromium, iron, nickel
and aluminium in some samples. In conclusion, the genotoxic metal mercury is found in normal
pancreatic cells in more people with, than without, pancreatic cancer. These findings support the
hypothesis that toxic metals such as mercury contribute to the pathogenesis of pancreatic cancer.
Keywords: pancreatic cancer; mercury; carcinogenesis; elemental analysis; pancreatic ductal
adenocarcinoma; toxic metal; risk factor; environmental toxicity; heavy metal; cadmium
1. Introduction
Worldwide, pancreatic cancer is the twelfth most common cancer, with the seventh-highest
mortality rate [1]. Only 5–10% of pancreatic cancer patients have a family history of pancreatic
cancer [2], so the search for environmental triggers for this cancer continues to aid interventions for
prevention and early detection [1]. Environmental factors considered to increase the risk of pancreatic
cancer include smoking, a high fasting plasma glucose, a high body-mass index, chronic pancreatitis,
and high alcohol consumption [1,3].
Genotoxic metals such as cadmium have also been proposed to play a part in the pathogenesis
of a variety of cancers [4], including pancreatic cancer [5–9]. Mercury is another heavy metal that
numerous experimental studies indicate has genotoxic potential, with recent reviews indicating that
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mercury causes DNA damage via multiple molecular mechanisms [10,11] (Figure 1). For example,
mercury binds tightly to DNA and causes single-strand breaks in DNA which are not repaired [12],
it promotes the formation of reactive oxygen species that damage DNA either directly or via forming
DNA reactive products, and it damages DNA repair enzymes, DNA polymerases, and microtubules
(reviewed in [10,11]). In humans exposed to mercury occupationally or via amalgam fillings, peripheral
lymphocyte studies indicate a genotoxic effect of mercury, and several human studies have suggested
increased cancer rates in people who have been exposed to mercury (reviewed in [10]). Humans are
commonly exposed to both methylmercury and mercury vapour, which are metabolised in the body to
toxic divalent mercury cations that accumulate in cells [13] (Figure 1). Particularly in people who have
genetic and other susceptibilities to mercury toxicity, divalent mercury cations have the potential to
trigger genetic changes that lead to cancer (Figure 1). However, the prevalence and distribution of
mercury in the human pancreas is not known.
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Figure 1. Hypothesis of mercury-induced pancreatic cancer. Mercury (Hg) exposure in humans is
common due to the uptake of either (1) methyl ercury ( eHg), which is slowly converted in cells to
more toxic divalent mercury cations (Hg2+), a ( ) rc ry vapour (Hg0) which is conv rted to Hg2+
in red blood cells and then passes into cells via transporters.
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Pancreatic islets, and nearby acinar and ductal cells, are susceptible to the uptake of xenobiotics since
they have a high blood flow and fenestrated capillaries. Mercury can trigger carcinogenesis either
through the production of oxygen free radicals, damage to microtubules and DNA repair mechanisms,
or direct damage to DNA [10]. People are more predisposed to mercury-induced carcinogenesis if they
have been exposed to multiple toxic metals (including Cd and Pb), if they have germline variants that
reduced DNA repair or increased mercury toxicity, or if they have deficiencies of selenium or other
anti-mercury defences.
The proposal that a direct link exists between mercury exposure and human cancers remains
controversial [4]. One obviously cannot intentionally expose people to mercury and see what cancers
they develop years later, but indirect evidence for such a link can be sought by looking for mercury in
normal pancreatic tissue adjacent to pancreatic tumours, and seeing if mercury here is more common
than in people who did not have pancreatic tumours. Determining the elemental composition of human
pancreatic cells is difficult, since islet cells make up only a small proportion of the total cell number,
and mercury in single or a small number of pancreatic cells could initiate a pancreatic neoplasm.
To overcome this problem, we employed two techniques that allow the in situ localisation of mercury
within tissues, i.e., the histochemical technique of autometallography which detects intracellular
mercury [14,15], and laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS) which
detects multiple elements [16]. We therefore studied pancreas samples containing normal pancreatic
tissue from people who had had surgery for pancreatic cancer and compared their pancreatic mercury
distribution, and how often they had pancreatic mercury, to people who did not have pancreatic cancer.
2. Materials and Methods
2.1. Ethics
This study (X14-029) was approved by the Human Research Committee, Sydney Local Health
District (Royal Prince Alfred Hospital Zone), and by the office of the New South Wales Coroner.
The institutional review board waived the need for written informed consent from patients or
relatives of deceased individuals studied since this was a de-identified retrospective study of archived
paraffin-embedded tissue.
2.2. Sample Collection
Paraffin sections of the pancreas containing at least 10 normal islets were obtained from two
sources: (1) The Sydney Royal Prince Alfred Hospital tissue archive supplied paraffin blocks from
pancreatectomies for pancreatic ductal adenocarcinoma (not otherwise specified) taken from 30 males
(mean age 69 years, age range 39–87 years, SD 13 years), and 15 females (mean age 69 years, age range
39–83 years, SD 13 years). De-identified tissue histopathology reports for these cases were obtained
from the Department of Tissue Pathology and Diagnostic Oncology at Royal Prince Alfred Hospital.
(2) The New South Wales Department of Forensic Medicine tissue archive supplied paraffin blocks
of pancreas taken as part of routine sampling from autopsies of people who did not have pancreatic
cancer, comprising 17 males (mean age 63 years, age range 35–96 years, SD 24 years), and 21 females
(mean age 74 years, age range 35–104 years, SD 27 years). The autopsy cases were selected from 103
pancreas samples in total, but 65 of these had post mortem autolytic changes and so were not suitable
for analysis. The Department of Forensic Medicine supplied de-identified information on the age,
gender, major pre-mortem clinical conditions, and causes of death for these samples. Major medical
conditions of the autopsy cases were: none known (N = 16), neurodegenerative disease (N = 16),
psychosis (N = 4), and one each of epilepsy and anorexia nervosa. Causes of death of the autopsy cases
were: cardiovascular (N = 11), suicide (N = 7), infection (N = 7), trauma (N = 5), drowning (N = 3),
drug overdose (N = 2), and one each of lung cancer, undernutrition, and undetermined.
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2.3. Mercury (Autometallography) Staining
Paraffin blocks were sectioned at 7µm with a Feather S35 stainless steel disposable microtome blade
and deparaffinised. Sections were stained for inorganic mercury using silver nitrate autometallography,
which represents the presence of mercury as black silver grains surrounding the mercury [17].
Autometallography is a sensitive amplification technique that can detect as few as 10 mercury
sulphide/selenide molecules in a cell [18]. Briefly, sections were placed in a physical developer
containing 50% gum arabic, citrate buffer, hydroquinone and silver nitrate at 26 ◦C for 80 min in the
dark then washed in 5% sodium thiosulphate to remove unbound silver. Sections were counterstained
with mercury-free hematoxylin and viewed with bright-field microscopy. Each staining run included a
control section of a mouse spinal cord where motor neuron cell bodies contained mercury following
an intraperitoneal injection of mercuric chloride [19]. Control pancreatic sections were stained with
hematoxylin only. Only one pancreas tissue block was available from the autopsy cases, so for valid
comparisons, only one block of the normal pancreas was examined from the pancreatectomy samples.
Islets containing mercury were identified using a 10 × 10 eyepiece grid viewed at 200×magnification
stepped sequentially throughout one autometallography-stained section. A mercury-stained islet
was defined as an islet (surrounded by normal acinar cells) where any cells contained more than 5
autometallography grains. The proportion of autometallography-stained islets was categorised as
+ if fewer than 50% of islets stained positively, and ++ when 50% or more islets stained positively.
The number and density of islets varied between individual samples, and mercury-stained islets
were usually patchy in distribution and present in small groups, so it was considered appropriately
conservative to compare the absence/presence of mercury-containing islets between pancreatic cancer
and non-cancer groups.
2.4. Laser Ablation-Inductively Coupled Plasma-Mass Spectrometry (LA-ICP-MS)
To confirm which metal autometallography was demonstrating (since autometallography can
also detect inorganic silver and bismuth), 7 µm paraffin sections of selected pancreas samples were
deparaffinised and subjected to LA-ICP-MS for mercury, silver, bismuth, aluminium, gold, cadmium,
chromium, iron, nickel and lead, as well as for zinc to localise islets due to their high zinc levels [20].
Analyses were carried out on a Teledyne Cetac LSX-213 G2+ laser (Omaha, NE, USA) hyphenated
to an Agilent Technologies 8900 ICP-MS (Santa Clara, CL, USA), with argon used as the carrier gas.
LA-ICP-MS conditions were optimised on NIST 612 Trace Element in Glass CRM (US Department
of Commerce, Gaithersburg, MD, USA) and the sample was ablated with a 50 µm spot size and a
scan speed of 100 µm/s at a frequency of 20 Hz. The data were collated into a single image file using
in-house developed software and visualised using FIJI open source image processing (LOCI, University
of Wisconsin, WI, USA).
2.5. Statistical Analyses
Prism v8.4 software (GraphPad, San Diego, CL, USA) was used to compare categorical variables
with contingency analyses and Fisher’s exact test.
3. Results
3.1. Mercury (Autometallography) Staining
3.1.1. Islet Cells
Islet cells were the most prone of the pancreatic cells to contain mercury (Table S1). Mercury
was present in the islets of 30 of the 83 samples (36%) from both pancreatectomy and autopsy groups
combined. In people with pancreatic cancer, 24 of 45 (53%) had islets that stained for mercury. The most
common distribution of mercury in these islets was in the cytoplasm of peripheral islet cells, with
either a few or many internal islet cells also containing mercury (Figure 2). Islet cells that were adjacent
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to microvessels, either the peripheral cells next to the circumferential vessels or the internal cells
adjacent to the interior vessels, were most likely to contain mercury. In all mercury-positive samples,
combinations of islets with or without mercury were seen. Mercury-positive islets were often arranged
in small clusters, with other islets being mercury-negative. In four of the pancreatectomy samples,
50% or more islets contained mercury (Table S1).
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Figure 2. Mercury in pancreatic islet cells. (A–C): pancreatectomy samples. (D): autopsy sample.
The areas in the dashed rectangles are shown at higher magnifications in the insets. (A) Black mercury
grains are present in most peripheral cells (e.g., arrowhead) of this islet, as well as in a few internal cells
adjacent to microvessels (e.g., arrow). (B) Black mercury grains in this islet are present in the cytoplasm
of all peripheral cells, as well as in most internal cells adjacent to microvessels. Two cells outside the
islet (arrow, probably ectopic islet cells) contain mercury. (C) Numerous dense black mercury granules
are visible within peripheral and internal cells of this islet, usually adjacent to cell nuclei. (D) Fine
black mercury grains are present in many scattered cells of this islet, with denser staining in three cells
(arrowheads). Autometallography/hematoxylin.
Six of 38 people (16%) without pancreatic cance had mercury-stained islets (Tabl S1). In five of
these, the mercury staining was mostly faint (Figure 2), and inv lved fewer than 50% of islets. Only one
auto sy sample had mercury staining involving more than 50% of islets.
Mercury was seen more often in islet cells in 14 of the 30 males (47%) with pancreatic cancer,
compared to two of the 17 males (12%) without pancreatic cancer (p = 0.024), and more often in 10 of the
15 females (67%) with pancreatic cancer, compared to four of the 21 females (19%) without pancreatic
cancer (p = 0.006).
To look for any effect of ageing on mercury in the pancreas, the proportion of the 83 people (in
both groups combined) with mercury-containing islets was calculated. The proportion of people in
increasing age quartiles with islet mercury was: 35–50 years: 43%, 51–72 years: 48%, 73–83 years: 36%,
and 84–104 years: 12%. Therefore, the mercury did not appear to accumulate in the pancreas on ageing.
The small proportion of mercury-containing islets in the 84–104 years group is likely to be due to the
larger proportion of non-pancreatic-cancer cases (88%) in this group.
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Gender did not appear to affect pancreatic uptake of mercury in the 83 people of both groups
combined, with 16 of the 47 males (34%) having mercury-containing islets, compared to 14 of the 36
females (39%) (p = 0.65).
There were not enough numbers in subgroups of non-pancreatic-cancer premortem medical
conditions or causes of death to undertake reliable statistical analyses of the prevalence of mercury in
these subgroups.
3.1.2. Acinar Cells
In 11 of the 45 people (24%) with pancreatic cancer (Table S1), mercury was seen in single or small
groups of acinar cells, usually in glands close to mercury-containing islets (Figure 3). Acinar cells
adjacent to non-mercury islets did not contain mercury. No acinar cells contained mercury in the 38
people without pancreatic cancer.
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Figure 3. Mercury in pancreatic acinar cells. The areas in the dashed rectangles are shown at
higher magnifications in the insets. (A) Some acinar cells (e.g., in the inset) contain black mercury
grains. A nearby large islet (arrow) has mercury-positive peripheral and internal cells. A small duct
(arrowhead) adjacent to the islet does not contain mercury. (B) A group of glands (within the dashed
rectangle) have acinar cells containing cytoplasmic mercury (inset). A nearby islet (ISL, within the
dashed line in the right lower corner) has peripheral cells (e.g., arrowhead) that contain mercury.
Autometallography/hematoxylin.
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3.1.3. Periductal Cells
Mercury was present in periductal cells in 5 of the 45 people (11%) with pancreatic cancer (Table S1).
In four of these, mercury was in cells abutting the epithelial cells of small intercalated or interlobular
ducts (Figure 4), usually close to mercury-containing islets. In one of these, mercury was also seen in a
few scattered oval cells abutting the epithelial cells of a larger interlobular pancreatic duct (Figure 4).
No periductal cells in the 38 people without pancreatic cancer contained mercury.
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3.2. LA-ICP-MS
3.2.1. Correlation of Mercury Detected on Autometallography with LA-ICP-MS
LA-ICP-MS images showed the high zinc levels normally present in islets, as well as the
overall cellularity of the sample (Figure 5). In four samples in which numerous islets stained with
autometallography, zinc-detected islets co-localised with LA-ICP-MS-detected mercury (Figures 5
and 6). In two autometallography-negative samples, no LA-ICP-MS mercury was seen in zinc-detected
islets (Figure S1).
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(A) A low power image of an autometallography/hematoxylin-stained pancreas sample shows
the exocrine tissue (blue-stained) and fatty infiltration (pale regions). (B,C) Examples of two of
the many islets in the sample (A) whose cells stained with autometallography (i.e., black grains).
Autometallography/hematoxylin. (D) An LA-ICP-MS zinc image demonstrates the islets as focal red
regions (examples in individually-dashed profiles). Yellow-green regions show the normal cellular
density of the exocrine pancreas. Dark blue spaces between cellular regions are due to fatty infiltration.
(E) An LA-ICP-MS mercury image shows mercury (red regions) in the same islets demonstrated by the
zinc imaging. Scale = counts per second (proportional to abundance).
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Figure 6. LA-ICP-MS of pancreatic samples containing AMG-positive islets. Zinc images show the
overall cellularity of the tissue (yellow-green) as well as pancreatic islets (red) that contain focally higher
zinc levels (some images may need to be enlarged to show these islets). (A) In this sample, mercury
co-localises with zinc-positive islets (the top two images are shown enlarged in Figure 5). Diffuse
chromium, and irregular cadmium and iron, are present. (B) Islet-located mercury and cadmium, focal
and diffuse lead, and irregular iron, nickel, and aluminium, are present in this sample. (C) In this sample,
islet-located mercury, diffuse chromium, and irregular cadmium and iron are present. (D) Islet-located
mercury, diffuse chromium, and irregular iron are present in this sample. Artefactual edge effects
are seen in some mercury, nickel, and chromium images (e.g., in (D)). Scale = counts per second
(proportional to abundance).
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3.2.2. Mercury and Other Toxic Metals Detected with LA-ICP-MS
In the four pancreas samples known to contain autometallography-positive islets, LA-ICP-MS
images of toxic metals were classified as being either negative (including non-specific background
levels and artefactual edge effects), focal (assumed to be in islets when aligned with zinc), diffuse, or
irregular (Figure 6). Cadmium was seen in islets in one sample and irregularly in two. Chromium
was present diffusely in three samples. Lead was present diffusely and focally in one sample. Iron
was present irregularly and/or diffusely in all samples, and at higher levels within the lumen of blood
vessels (presumably due to high iron levels in red blood cells). Nickel was seen irregularly, in the same
distribution as iron, in one sample. Aluminium was present irregularly in one sample. In two samples
with no autometallography staining (Figure S1), numerous LA-ICP-MS zinc-positive islets were seen,
but no mercury was detected; cadmium was present diffusely in the pancreatic tissue of both samples,
but not increased in islets. No silver, bismuth, or gold was detected in any samples.
4. Discussion
Key findings in this study are that mercury is present in pancreatic islet cells in a greater proportion
of people with pancreatic cancer than those without pancreatic cancer, and that in several people with
pancreatic cancer, individual acinar and periductal cells also contained mercury (Table S1). Other toxic
metals, in particular cadmium and chromium, were found in selected samples (see Results). These
findings suggest an association exists between mercury in pancreatic cells and pancreatic cancer, but as
always, association does not prove causation [21]. We hope, though, our findings will promote further
investigations into the role toxic metals play in the pathogenesis of pancreatic cancer.
Mercury in our pancreatic samples was found predominantly in islet cells, possibly because the
plentiful capillaries that encircle and penetrate islets (which receive blood before the other pancreatic
cells) are fenestrated [22,23] and so would more readily allow xenobiotics to pass into them. Some
acinar and periductal cells adjacent to mercury-containing islets also contained mercury, probably
because they share the same fenestrated capillaries that supply the nearby islets [24]. The preference of
mercury to enter islets cells is of interest since these cells can differentiate into both pancreatic and
extra-pancreatic cells, and they contain numerous carcinogen-metabolising enzymes, suggesting they
play a role in carcinogenesis [25]. Mercury is a genotoxin [10,26] that has previously been implicated
in the pathogenesis of neoplasms such as breast cancer [16,27]. The carcinogenic potential of mercury
would be enhanced if it were present in progenitor cells since these cells when dividing are likely to
be susceptible to the genotoxic properties of mercury [10,11]. However, uncertainty remains as to
the location of progenitor cells in the human pancreas, with the possibility that they exist in islets,
acini, or ducts, or all three locations [25,28–32]. Future studies combining elemental biomapping with
immunostaining for progenitor and stem cell markers would be required to accurately determine the
nature of these mercury-containing pancreatic cells.
The amount of mercury in the atmosphere is steadily increasing, mostly due to the burning
of fossil fuels such as coal [33]. This is likely to be a factor in the increased bioaccumulation of
mercury in fish [34], and seafood consumption is the major source of mercury exposure in humans [35].
Elevated blood levels of mercury have been recorded in people consuming recommended levels
of seafood [36], and in avid consumers of seafood this mercury may increase markers of oxidative
stress [37]. Mercury-triggered carcinogenesis might therefore be one factor contributing to the increasing
incidence of pancreatic cancer that has been reported by several epidemiological studies [38], though
some of this increase in incidence could be due to ageing populations [1].
There was no age-related increase in islet mercury in our combined samples. This is unlike findings
in the brain [39] and pituitary [40] where greater proportions of older people had mercury-containing
cells. This raises the possibility that people with pancreatic cancer are on average likely to have had
a greater environmental exposure to mercury from sources such as seafood, dental amalgams, or
occupations, compared to people without pancreatic cancer. Another possible explanation is that
people with pancreatic cancer have a genetic susceptibility to either the cellular uptake of mercury
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(eg, by mercury transporters [41]) or the retention of mercury in their pancreatic cells. Pancreatic
cancer could in some way change the internal milieu of the remainder of the normal pancreatic tissue,
possibly by increasing blood flow, that aids the entry of mercury into pancreatic cells. Alternatively,
suppressed metabolic activity in the remaining normal pancreas of people with pancreatic cancer
could theoretically depress mercury excretion from the cells, thereby raising intracellular mercury
levels. Future case-control studies of dietary habits, dental mercury-containing amalgam fillings [42],
and occupations in people with and without pancreatic cancer are needed to shed light on whether
any of these environmental sources of mercury are risk factors for pancreatic cancer. Genetic studies
looking for differences in mercury toxicokinetics in people with pancreatic cancer would also be of
interest [43].
Other potentially toxic metals found in our pancreatic samples were cadmium, chromium, lead,
iron, nickel, and aluminium. (1) Cadmium is a genotoxin [44,45] that has been proposed to play a role
in pancreatic cancer [5–7]. A major source of human exposure to cadmium is cigarette smoke [46],
an established risk factor for pancreatic cancer [3,47], as well as rice in some countries such as
Japan [48]. There is no histochemical technique to localise cadmium within individual cells, but
cadmium appeared regularly in our pancreatic tissue samples studied with LA-ICP-MS. (2) High
concentrations of chromium are found in the pancreatic juice of people with pancreatic carcinoma [49].
(3) An excess of pancreatic cancer mortality is found in people occupationally exposed to lead [50],
and high toenail levels of lead are associated with an increased risk of pancreatic cancer [6]. (4)
Iron excess is implicated in carcinogenesis due to its ability to damage DNA via the generation of
oxygen radicals [51]. (5) Nickel is classified as a carcinogen [45], though high toenail levels of nickel
are suggested to be associated with a lower risk of pancreatic cancer [6]. (6) There is conflicting
evidence about the carcinogenicity of aluminium, though it can cross-link proteins and induce oxidative
stress [52].
Mixtures of heavy metals were commonly seen in our pancreatic samples. This could be relevant
to carcinogenesis since many heavy metals are classified as carcinogens [45], and toxicity-enhancing
synergy between heavy metals is being increasingly recognized [53]. Cigarette smoke, in addition to
containing cadmium, also contains chromium, lead and nickel [54], which accumulate in tissues after
prolonged smoking [46] and could be a source of these metals found in our pancreas samples, though
we did not have access to histories of smoking habits.
Our finding that mercury is found in a variety of human pancreatic cells, often together with
other toxic heavy metals, supports previous proposals that heavy metals with genotoxic [10,11,44],
autoimmune [55], or oxidative effects [56] could play a part in the pathogenesis of both pancreatic
cancer [5–9] and diabetes mellitus [57–64]. In pancreatic cancer, most attention until now has been
given to the possible role of cadmium [5,7–9], whereas both mercury [58–60,63] and cadmium [64] are
suspected to contribute to the pathogenesis of diabetes. Metal toxicity in these pancreatic disorders
could be enhanced by synergistic actions between toxic metals [53], as well as by genetic susceptibilities
to metal toxicity [65], autoimmunity [66], and oxidative damage [56] (Figure 7).
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interest to see if these early lesions contained toxic metals. (9) We did not have access to the stage or
location of the pancreatic tumours, so we are unable to correlate these with mercury in the pancreas.
5. Conclusions
In conclusion, mercury is found in normal pancreatic islet, acinar, and periductal cells more often
in people with pancreatic cancer than people without this cancer. Mercury has genotoxic effects, so
these findings support the hypothesis that toxic metals such as mercury contribute to the pathogenesis
of pancreatic cancer. In addition, the finding of mercury and cadmium in human pancreatic islets
supports proposals that these metals play a role in diabetes mellitus. Further investigations of multiple
toxic metals in pancreatic cells of people with pancreatic cancer and diabetes mellitus are needed to
provide more evidence for the role of toxic metals in the pathogenesis of these disorders.
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(proportional to abundance). Table S1: Ages, gender, and mercury (autometallography) staining in pancreatic
samples from people with and without pancreatic cancer.
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